Goodbye Crop Diversity
Here’s a picture from National Geographic showing a stunning decline in the genetic diversity of crops:
This is dangerous – diversity is key to avoiding crop failures from disease and pestilence.
Similar Posts
The USA Is Number One… In Healthcare Prices!
ByadminThe folks at Vox media put together a series of pictures, illustrating how much more expensive medical care is in United States compared to other developed countries. Today, and in the next few days, I’m going to circulate some of those pictures. Prepare yourself for horror! Take medications, for example. (Please!) Pills for rheumatoid arthritis…
When It Comes to Healthcare, Republicans Have a Trust Problem
ByadminHere is some polling data, on a wide range of health and healthcare issues. It shows pretty consistently that Americans trust Democrats more than Republicans on these issues: I think it’s time for Republicans to move beyond “repeal and replace” and start showing the American people that they have productive ideas about how to improve…
Republicans Hate Obamacare so Much, They Refuse to Benefit from It?
ByadminHere is a chart from the Washington Post, showing the percent of people lacking health insurance over the last few years. For a long time now, a higher proportion of Democrats have been uninsured than Republicans, with low income and minority communities experiencing a disproportionately high uninsurance rate. But since Obamacare has come into effect,…
Talking about Healthcare Costs with Your Oncologist
ByadminMy colleagues and I just published a study in The Journal of Oncology Practice, showing what happens when the topic of healthcare costs comes up during oncology clinic appointments. Check out this nice news article discussing our findings: Even brief conversations between oncologists and patients about cancer costs can help reduce treatment expenses, a new…
The History of Tobacco Control — In One Picture
ByadminCame across this cool graphic, showing the rise and fall of U.S. cigarette consumption. The picture also shows when various policy levers were pulled, and how those levers track to consumption. WARNING: No proof of cause and effect. But still quite interesting.
Copay Assistance Controversy Continues
ByadminMy article with Peter Bach of Memorial Sloan Kettering continues to generate debate. The two of us argues that copay assistance programs from pharmaceutical companies help specific patients in the short run, but make it easier for drug companies to demand high prices for their products. Here is one take on the topic, spurred on…